Immune Effects

Immune overview

Curcumin is not purely anti-inflammatory in a simplistic sense. In cancer biology, it appears to modulate the immune system in a direction that may support anti-tumour activity while also reducing chronic inflammatory signalling that tumours exploit.

Reported immune effects

Th1 support

• May increase IFN-γ and other cell-mediated immune signals

• May reduce tumour-associated Th2 skewing in some settings

Macrophage polarisation

• May favour M1-like anti-tumour macrophage activity

• May reduce M2-like tumour-supportive macrophage features

NK-cell function

• May enhance NK-cell cytotoxicity in preclinical models

• May support tumour-cell killing capacity

Dendritic-cell effects

• May improve maturation and antigen-presentation behaviour

• Could support better T-cell priming in tumour-immune contexts

Additional immune relevance

• May reduce myeloid-derived suppressor cell activity

• May improve the immune microenvironment in selected tumour settings

• Has early research interest as a checkpoint-therapy support compound, though this is not yet established clinically

Practical takeaway

Curcumin's immune effects add to its appeal as an adjunctive compound. They should still be interpreted through the lens of tumour type, immune state, treatment timing, and formulation quality.